MercadanteS, VillariP, FerreraPet al.Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine. J Pain Symptom Manage, 2006; 32:175–179.
3.
JaliliM, FathiM, Moradi-LakehM, ZehtabchiS. Sublingual buprenorphine in acute pain management: A double-blind randomized clinical trial. Ann Emerg Med, 2012; 59:276–280.
4.
MercadanteS, CasuccioA, TirelliW, GiarratanoA. Equipotent doses to switch from high doses of opioids to transdermal buprenorphine. Support Care Cancer, 2009; 17:715–718.
5.
JasinskiDR, PevnickJS, GriffithJD. Human pharmacology and abuse potential of the analgesic buprenorphine: A potential agent for treating narcotic addiction. Arch Gen Psychiatry, 1978; 35:501–516.
MercadanteS, FerreraP, VillariP. Is there a ceiling effect of transdermal buprenorphine? Preliminary data in cancer patients. Support Care Cancer, 2007; 15:441–444.
8.
PergolizziJVJr, MercadanteS, EchaburuAVet al.The role of transdermal buprenorphine in the treatment of cancer pain: An expert panel consensus. Curr Med Res Opin, 2009; 25:1517–1528.
9.
Rodriguez-LopezM. Transdermal buprenorphine in the management of neuropathic pain. Rev Soc Esp Dolor, 2004; 11,Suppl V:11–21.
10.
PenzaP, CampanellaA, MartiniAet al.Short- and intermediate-term efficacy of buprenorphine TDS in chronic painful neuropathies. J Peripher Nerv Syst, 2008; 13:283–288.
11.
KoppertW, IhmsenH, KörberNet al.Different profiles of buprenorphine-induced hyperalgesia and antihyperalgesia in a human pain model. Pain, 2005; 118:15–22.
12.
PergolizziJ, AloisiAM, DahanAet al.Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract, 2010; 10:428–450.
13.
LikarR, VadlauEM, BreschanC, KagerI, Korak-LeiterM, ZiervogelG. Comparable analgesic efficacy of transdermal buprenorphine in patients over and under 65 years of age. Clin J Pain, 2008; 24:536–543.
14.
BachV, Kamp-JensenM, JensenNHet al.Buprenorphine and sustained release morphine: Effect and side-effects in chronic use. Pain Clinic, 1991; 4:87–93.
15.
LikarR, KayserH, SittlR. Long-term management of chronic pain with transdermal buprenorphine: A multicenter, open-label, follow-up study in patients from three short-term clinical trials. Clin Ther, 2006; 28:943–952.
